Non-invasive determination of hypoxia is an important problem in clinical nuclear medicine. Although 18 F-fluoromisonidazole is used clinically for hypoxia determination, the short half-life (t 1/2 = 109.77 min), high cost and less availability of cyclotrone-produced 18 F make 99m Tc (t 1/2 = 6 h)-b
Synthesis, radiolabeling and evalution of 99mTc(CO)3-labeled misonidazole analogue to target tumor hypoxia
β Scribed by Madhava B. Mallia; Anupam Mathur; Sharmila Banerjee; H.D. Sarma; Meera Venkatesh
- Book ID
- 116799515
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 206 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0969-8051
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Dendrimer polyamidoamine generation fiveβfolic acid conjugate was synthesesed and radiolabelled with __fac__β[^99m^Tc(CO)~3~(H~2~O)~3~]^+^, its __in vitro__ stability was evaluated further. Both of the labeling yield and radiochemical purity of the G5βFAβDTPAβ^99m^Tc(CO)~3~ conjugate ex
## Abstract Determination of hypoxia in tumor is an important problem in the clinical management of cancer. Towards this, a series of differently substituted nitroimidazoles, viz. 2βnitro, 4βnitro and 5βnitroimidazole iminodiacetic acid (IDA) derivatives were synthesized and radioβlabeled with a [^